EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic Markers of Helicobacter pylori Resistance to Clarithromycin and Levofloxacin in Moscow, Russia

Natalia Bodunova iD, Larisa Tsapkova iD, Vera Polyakova iD, Irina Baratova iD, Konstantin Rumyantsev iD, Natalia Dekhnich iD, Karina Nikolskaya iD, Margarita Chebotareva iD, Irina Voynovan iD, Elena Parfenchikova iD, Galina Pronina iD, Ekaterina Chernikova und 1 weitere

Current Issues in Molecular Biology · 29.06.2024 · 46 (7) · 6665-6674

DOI: 10.3390/cimb46070397 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 29.06.2024. Verfasst von Natalia Bodunova und 12 weiteren Autor:innen. Beteiligte Einrichtung: A.S. Loginov Moscow Clinical Scientific Center, 111123 Moscow, Russia. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSRD VA, “Moscow Center for Innovative Technologies in Healthcare” of the Moscow Healthcare Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Maastricht VI/Florence consensus recommends, as one of the measures to enhance the efficacy of Helicobacter pylori infection eradication, a personalized treatment approach involving the selection of an antimicrobial agent based on the pre-determined resistance of H. pylori. To address the need to develop test systems for personalized drug selection, this study was designed to analyze the molecular resistance of H. pylori using a newly developed Sanger sequencing test platform. The characteristics of the test system were determined on 25 pure culture samples of H. pylori with known resistance. Sensitivity and specificity for detecting resistance to clarithromycin was 100% and those to levofloxacin were 93% and 92%, respectively. The test system has been tested in real clinical practice on 112 H. pylori-positive patients who had not previously received proton pump inhibitors (PPIs) or antibacterial drugs. Mutations indicating resistance to clarithromycin were found in 27 (24%) samples and those indicating resistance to levofloxacin were found in 26 (23%) samples. Double resistance was observed in 16 (14%) samples. The most common mutations leading to clarithromycin resistance were 2143G and 2142G and to levofloxacin resistance—261A and 271A in the gyrA gene, which account for 69% of all identified genetic determinants in levofloxacin-resistant bacteria. Thus, a personalized approach to the selection of H. pylori eradication therapy based on the detection of bacterial resistance before prescribing first-line therapy could help to avoid the prescription of ineffective H. pylori eradication therapies and, overall, contribute to the control of antibiotic resistance of H. pylori.

Schlagwörter

Stichwörter der Autor:innen

Helicobacter pyloriantibiotic resistancegeographical distribution of H. pylori antibiotic resistancemethods for determining H. pylori resistancemolecular genetic diagnosticsphenotypic methods for determining antibiotic resistance

Autor:innen und Institutionen

  • A.S. Loginov Moscow Clinical Scientific Center, 111123 Moscow, Russia.
  • Department of Faculty Therapy, Smolensk State Medical University of the Ministry of Health of Russia, 214019 Smolensk, Russia.
  • Department of Propaedeutics of Internal Diseases and Gastroenterology of the Faculty of Medicine, Russian University of Medicine, 127473 Moscow, Russia.
  • Department of Family Medicine and General Medical Practice, Tver State Medical University, 170100 Tver, Russia.

ORCID-Profile: Natalia Bodunova, Larisa Tsapkova, Vera Polyakova, Irina Baratova, Konstantin Rumyantsev, Natalia Dekhnich, Karina Nikolskaya, Margarita Chebotareva, Irina Voynovan, Elena Parfenchikova, Galina Pronina, Dmitry Bordin

Förderung

  • CSRD VA
  • “Moscow Center for Innovative Technologies in Healthcare” of the Moscow Healthcare Department

Zitieren

APA

Bodunova, N., Tsapkova, L., Polyakova, V., Baratova, I., Rumyantsev, K., Dekhnich, N., Nikolskaya, K., Chebotareva, M., Voynovan, I., Parfenchikova, E., Pronina, G., Chernikova, E., & Bordin, D. (2024). Genetic Markers of Helicobacter pylori Resistance to Clarithromycin and Levofloxacin in Moscow, Russia. Current Issues in Molecular Biology, 46(7), 6665-6674. https://doi.org/10.3390/cimb46070397

Vancouver

Bodunova N, Tsapkova L, Polyakova V, Baratova I, Rumyantsev K, Dekhnich N, et al. Genetic Markers of Helicobacter pylori Resistance to Clarithromycin and Levofloxacin in Moscow, Russia. Current Issues in Molecular Biology. 2024;46(7):6665-6674. doi:10.3390/cimb46070397

BibTeX
@article{Bodunova2024,
  author = {Bodunova, Natalia and Tsapkova, Larisa and Polyakova, Vera and Baratova, Irina and Rumyantsev, Konstantin and Dekhnich, Natalia and Nikolskaya, Karina and Chebotareva, Margarita and Voynovan, Irina and Parfenchikova, Elena and Pronina, Galina and Chernikova, Ekaterina and Bordin, Dmitry},
  title = {Genetic Markers of Helicobacter pylori Resistance to Clarithromycin and Levofloxacin in Moscow, Russia},
  journal = {Current Issues in Molecular Biology},
  year = {2024},
  volume = {46},
  number = {7},
  pages = {6665--6674},
  doi = {10.3390/cimb46070397}
}
Kostenlos starten →